13-10-2026 06:36 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  About Us   Services             Trading   Depository    
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Quarterly Results
Symbiotec Pharmalab Ltd.
 
BSE Code 544889
ISIN Demat INE899I01028
Book Value 0.00
NSE Code SYMBIOTEC
Dividend Yield % 0.00
Market Cap 70771.68
P/E 79.57
EPS 13.84
Face Value 2  
Quarters :
(Rs. in Million)
Particulars (Rs in Million) Jun 2026Jun 2025
 Audited / UnAudited UnAudited UnAudited
Net Sales 2108.43 2042.62
Total Expenditure 1516.03 1419.16
PBIDT (Excl OI) 592.40 623.46
Other Income 195.47 114.74
Operating Profit 787.87 738.20
Interest 56.20 51.14
Exceptional Items 0 0
PBDT 731.67 687.06
Depreciation 101.47 92.99
Profit Before Tax 630.20 594.07
Tax 160.12 149.02
Provisions and contingencies 0 0
Profit After Tax 470.08 445.05
Extraordinary Items 0 0
Prior Period Expenses 0 0
Other Adjustments 0.00 0.00
Net Profit 470.08 445.05
Equity Capital 125.47 109.36
Face Value (IN RS) 2 2
Reserves  
Calculated EPS 7.49 8.14
Calculated EPS (Annualised) 29.97 32.56
Calculated Adj_EPS 7.49 8.14
No of Public Share Holdings 0 0
% of Public Share Holdings 0 0
   
PBIDTM% (Excl OI) 28.10 30.52
PBIDTM% 37.37 36.14
PBDTM% 34.70 33.64
PBTM% 29.89 29.08
PATM% 22.30 21.79
 Notes Notes
 
Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors
KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
Few Important Links: NSE | BSE | NSDL | CDSL | SEBI | MCX | NCDEX | FMC | RBI | AMFI | My Company GST Number | SCORES | DP 15 | BSE PLUS
Contact Us | Careers | Downloads | Notice |Margin Obligation Circular |Creating Investor | Policies| Details of KMPS | Public information for Investors
Circular | BOI UPI ID & QR Code | Research Analyst Certificate | Internal policy RA
SEBI Reg. No INZ000209538 Depository CDSL: IN-DP-15-2015 Research Reg. No.: INH000011219
© 2006 J G Shah Financial Consultants Pvt.Ltd. All rights reserved.
Designed || Developed & Content Powerd By Accord Fintech Pvt. Ltd.